Publication Cover
Mitochondrial DNA
The Journal of DNA Mapping, Sequencing, and Analysis
Volume 26, 2015 - Issue 1
159
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Sequence polymorphisms in the D-loop region of mitochondrial DNA and outcome of non-Hodgkin lymphoma

, , , , , & show all
Pages 88-91 | Received 07 May 2013, Accepted 04 Jul 2013, Published online: 11 Sep 2013

References

  • Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. (2007). Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67:4687–94
  • Bandy B, Davision AJ. (1990). Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic Biol Med 8:523–39
  • Beal MF. (1996). Mitochondia, free radicals, and neurodegeneration. Curr Opin Neurobiol 6:661–6
  • Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, Wu LL, et al. (2012). Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma. Int J Cancer 131:1095–103
  • DiMauro S, Schon EA. (2001). Mitochondrial DNA mutations in human disease. Am J Med Genet 106:18–26
  • Ding C, Li R, Wang P, Fan H, Guo Z. (2012a). Sequence polymorphisms of the mitochondrial displacement loop and outcome of non-small cell lung cancer. Exp Ther Med 3:861–4
  • Ding C, Li R, Wang P, Jin P, Li S, Guo Z. (2012b). Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondr DNA 23:251–4
  • Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. (2000). Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017–19
  • Gao Y, Zhao G, Diao L, Guo Z. (2013). Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for non-Hodgkin lymphoma. Mitochondr DNA. [Epub ahead of print]
  • Gascoyne RD. (2004). Emerging prognostic factors in diffuse large B cell lymphoma. Curr Opin Oncol 16:436–41
  • Geyer SM, Morton LM, Habermann TM, Allmer C, Davis S, Cozen W, Severson RK, et al. (2010). Smoking, alcohol use, obesity, and overall survival from Non-Hodgkin lymphoma: A population-based study. Cancer 116:2993–3000
  • Gille JJ, Joenje H. (1992). Cell culture models for oxidative stress: Superoxida and hydrogen peroxidative versus normobaric heperoxia. Mutant Res 275:405–14
  • Han X, Kilfoy B, Zheng T, Holford TR, Zhu C, Zhu Y, Zhang Y. (2008). Lymphoma survival patterns by WHO subtype in the United States, 1973--2003. Cancer Causes Control 19:841–58
  • Kube D, Hua TD, von Bonin F, Schoof N, Zeynalova S, Klöss M, Gocht D, et al. (2008). Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: An exploratory study. Clin Cancer Res 14:3777–84
  • Kumimoto H, Yamane Y, Nishimoto Y, Fukami H, Shinoda M, Hatooka S, Ishizaki K. (2004). Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer 108:228–31
  • Lan Q, Zheng T, Shen M, Zhang Y, Wang SS, Zahm SH, Holford TR, et al. (2007). Genetic polymorphism in the oxidative stress pathway susceptibility to non-Hodgkin lymphoma. Hum Genet 121:161–8
  • Lawless MW, O’Byme KJ, Gray SG. (2009). Oxidative stress induced lung cancer and COPD: Opportunities for epigenetic therapy. J Cell Mol Med 13:2800–21
  • Lightfoot TJ, Skibola CF, Smith AG, Forrest MS, Adamson PJ, Morgan GJ, Bracci PM, et al. (2006). Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica 91:1222–7
  • Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. (1997). Mammalian mitochondrial genetics: Heredity, heteroplasmy and disease. Trends Genet 13:450–5
  • Loft S, Svoboda P, Kawai K, Kasai H, Sørensen M, Tjønneland A, Vogel U, et al. (2012). Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study. Free Radic Biol Med 52:167–72
  • Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, et al. (2006). Mitochondrial DNA D-loop in pancreatic cancer: Somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol 126:593–601
  • Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, et al. (2001). Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61:1843–5
  • Pala M, Achilli A, Olivieri A, Hooshiar Kashani B, Perego UA, Sanna D, Metspalu E, et al. (2009). Mitochondrial haplogroup U5b3: A distant echo of the epipaleolithic in Italy and the legacy of the early Sardinians. Am J Hum Genet 84:814–21
  • Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, et al. (2001). Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61:7015–19
  • Shigenaga MK, Hagen TM, Ames BN. (1994). Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91:10771–8
  • Shipp MA. (1994). Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has “high-risk” disease? Blood 83:1165–73
  • Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, et al. (2004). Follicular lymphoma international prognostic index. Blood 104:1258–65
  • Stoneking M. (2000). Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet 67:1029–32
  • Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. (2008). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC
  • Taanman JW. (1999). The mitochondrial genome: Structure, transcription, translation and replication. Biochim Biophys Acta 1410:103–123
  • Wallace DC. (2001). Mouse models for mitochondrial disease. Am J Med Genet 106:71–93
  • Wang C, Zhang F, Fan H, Peng L, Zhang R, Liu S, Guo Z. (2011). Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome. Biochem Biophys Res Commun 406:493–6
  • Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. (2007). Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 16:1455–9
  • Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, Isaya G, et al. (2008). Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17:3558–66
  • Wang SS, Davis S, Cerhan JR, Hartge P, Severson RK, Cozen W, Lan Q, et al. (2006). Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 27:1828–34
  • Yoneyama H, Hara T, Kato Y, Yamori T, Matsuura ET, Koike K. (2005). Nucleotide sequence variation is frequently in the mitochondrial DNA displacement loop region of individual human tumor cells. Mol Cancer Res 3:14–20
  • Zhang R, Wang R, Zhang F, Wu C, Fan H, Li Y, Wang C, Guo Z. (2010a). Single nucletide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res 29:155
  • Zhang R, Zhang F, Wang C, Wang S, Shiao YH, Guo Z. (2010b). Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res 29:130

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.